NCT03676933View on ClinicalTrials.gov

Efficacy and Steroid Sparing Potential Study of DGLA Cream in Early Childhood Patients With Moderate to Severe Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 25, 2016

Conditions
Atopic Dermatitis
Interventions
DRUG

DS107E

DRUG

Vehicle

DRUG

Hydrocortisone Butyrate 0.1% Cream

Steroid taken topically once a day

Trial Locations (1)

Unknown

DS Biopharma Investigational Site, Dublin

Sponsors

Lead Sponsor

DS Biopharma
All Listed Sponsors
lead

DS Biopharma

INDUSTRY